Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Ceska

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Psychiatry Research|March 3, 2005
Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmissionJan Vevera, Zdenĕk Fisar, Tomás Kvasnicka, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|December 22, 2017
MRAS gene marker rs9818870 is not associated with acute coronary syndrome in the Czech population and does not predict mortality in males after acute coronary syndromeJaroslav A Hubacek, Vladimir Stanek, Marie Gebauerova, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 21, 2018
Body Adiposity Changes After Lifestyle Interventions in Children/Adolescents and the NYD-SP18 and TMEM18 VariantsLukas Zlatohlavek, Vit Maratka, Eva Tumova, et al.
Neuro Endocrinology Letters|February 20, 2008
Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitusMichal Vrablík, Milada Dobiásová, Tomás Stulc, et al.
Neuro Endocrinology Letters|November 28, 2012
The role of a center for tobacco-dependent in cardiovascular prevention. A retrospective studyKamila Zvolska, Eva Kralikova, Alexandra Kmetova, et al.
Molecular Diagnosis & Therapy|June 22, 2019
The Gene Score for Predicting Hypertriglyceridemia: New Insights from a Czech Case-Control StudyJaroslav A Hubacek, Dana Dlouha, Vera Adamkova, et al.
Pharmacogenomics|June 18, 2009
Impact of apolipoprotein A5 variants on statin treatment efficacyJaroslav A Hubacek, Vera Adamkova, Martina Prusikova, et al.
Experimental and Clinical Cardiology|July 31, 2009
Apolipoprotein AV gene polymorphisms (T-1131/C and Ser19/Trp) influence plasma triglyceride levels and risk of myocardial infarctionJaroslav A Hubacek, Zdena Skodova, Vera Adamkova, et al.
American Heart Journal|October 3, 2002
Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemiaVojtech Melenovsky, Jan Malik, Dan Wichterle, et al.
Human Genetics|October 24, 2008
MLXIPL variant in individuals with low and high triglyceridemia in white population in Central EuropeMichal Vrablik, Richard Ceska, Vera Adamkova, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Psychiatry Research|March 3, 2005
Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmissionJan Vevera, Zdenĕk Fisar, Tomás Kvasnicka, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|December 22, 2017
MRAS gene marker rs9818870 is not associated with acute coronary syndrome in the Czech population and does not predict mortality in males after acute coronary syndromeJaroslav A Hubacek, Vladimir Stanek, Marie Gebauerova, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 21, 2018
Body Adiposity Changes After Lifestyle Interventions in Children/Adolescents and the NYD-SP18 and TMEM18 VariantsLukas Zlatohlavek, Vit Maratka, Eva Tumova, et al.
Neuro Endocrinology Letters|February 20, 2008
Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitusMichal Vrablík, Milada Dobiásová, Tomás Stulc, et al.
Neuro Endocrinology Letters|November 28, 2012
The role of a center for tobacco-dependent in cardiovascular prevention. A retrospective studyKamila Zvolska, Eva Kralikova, Alexandra Kmetova, et al.
Molecular Diagnosis & Therapy|June 22, 2019
The Gene Score for Predicting Hypertriglyceridemia: New Insights from a Czech Case-Control StudyJaroslav A Hubacek, Dana Dlouha, Vera Adamkova, et al.
Pharmacogenomics|June 18, 2009
Impact of apolipoprotein A5 variants on statin treatment efficacyJaroslav A Hubacek, Vera Adamkova, Martina Prusikova, et al.
Experimental and Clinical Cardiology|July 31, 2009
Apolipoprotein AV gene polymorphisms (T-1131/C and Ser19/Trp) influence plasma triglyceride levels and risk of myocardial infarctionJaroslav A Hubacek, Zdena Skodova, Vera Adamkova, et al.
American Heart Journal|October 3, 2002
Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemiaVojtech Melenovsky, Jan Malik, Dan Wichterle, et al.
Human Genetics|October 24, 2008
MLXIPL variant in individuals with low and high triglyceridemia in white population in Central EuropeMichal Vrablik, Richard Ceska, Vera Adamkova, et al.
Pageof 6